Scientific Research

It’s what’s inside that tells us apart.

Our extensive research has shown that Agathomycin and Agathos-Active, distilled from the Buchu plant, has potent anti-inflammatory properties. It has revealed that the Agathomycin and Agathos-Active extract inhibits both the acute and chronic inflammatory processes by inhibiting the synthesis and release of pro-inflammatory factors which cause tissue damage. In comparison to known molecules described as having anti-inflammatory properties (e.g. Quercetin), the Agathomycin and Agathos-Active extract has an average of a 60% higher activity at an equivalent concentration.

Testimony to products efficacy include the following:
“Most effective natural anti-inflammatory I have ever come across.”
Geoff Woodruff

Five-times South African champion trainer

“More effective than other gels and safer than clay as you can apply to cuts and rubs.”
Somerville Lodge Racing, Newmarket, UK

“Stunning product for Colic, sorted my horse within minutes. Will never not be without again.”
Georgia Kelly, Virginia, USA

“I have used the topical gel on Haematoma, which has stopped the need to have them lanced and traumas caused from kicks which have brought the swelling down and pain for the horse overnight.”
Gary Player, Stud Farm

“Nature’s wonder natural anti-inflammatory and pain reliever.”
Prof. Patrick Bouic, Immunologist

Natural Medicine Journal

Health24
Cape Talk

Such anecdotes and
testimonials included the following:

The products are known to be safe and natural: the Agathomycin and Agathos-Active extract carries a GRAS status (Generally Recognised as Safe) with FDA and EU Commission since it is currently used in foodstuffs and beverages. They do not contain any known toxic molecules or banned substances and can therefore be used by animals and pets.

Since 1999, research has been undertaken by leading academic research institutions to identify the bioactive molecules within Agathomycin and Agathos-Active, and to scientifically substantiate its many claimed health benefits. This was due to the release into the South African market of a herbal extract containing Agathomycin and Agathos-Active, and subsequent anecdotal testimonials were reported by users of its healing potential.

Based on the above mentioned properties measured in vitro, the University of Cape Town, in collaboration with Prof. Tim Noakes and his team, have undertaken clinical studies in humans. The first was to determine the protective action of the gel containing the Agathomycin and Agathos-Active (buchu extract) which was applied topically in prevention of muscle damage and trauma in a model of exercise-induced inflammation.

Based on the above mentioned research, further scientific research was carried out to determine the anti-bacterial properties of the Agathomycin and Agathos-Active. We were able to conclude both in vitro and in vivo that the extract was extremely effective against both gram-negative and gram-positive pathogens. In particular, H. pylori, E. coli and Staff aureus.